NCT07529808: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 164 planned
- Started
- 16 Jul 2026
- Primary completion
- Dec 2028
- Arms
- Dose Escalation and Backfill Cohorts, Recommended Phase 2 Dose Level 1 (RP2D1), Recommended Phase 2 Dose Level 2 (RP2D2)
- Results
- None posted
- 14 Apr 2026: Trial registered
- 16 Jul 2026: Trial started